期刊
CANCER GENE THERAPY
卷 9, 期 12, 页码 1062-1067出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.cgt.7700548
关键词
oncolytic; virotherapy; experimental therapeutics; cancer
The field of replication-selective oncolytic viruses (virotherapy) has exploded over the last 10 years. As with many novel therapeutic approaches, initial overexuberance has been tempered by clinical trial results with first-generation agents. Although a number of significant hurdles to this approach have now been identified, novel solutions have been proposed and improvements are being made at a furious rate. This article seeks to initiate a discussion of these hurdles, approaches to overcome them, and unique safety and regulatory issues to consider.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据